ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC31605-100mg |
|
16284-60-9 |
N-Isovaleroylglycine
|
0 | C7H13NO3 | |
GC31604-20mg |
|
872313-42-3 |
Compound 2
|
0 | C21H23ClO6 | |
GC31604-10mg |
|
872313-42-3 |
Compound 2
|
0 | C21H23ClO6 | |
GC31604-5mg |
|
872313-42-3 |
Compound 2
|
0 | C21H23ClO6 | |
GC31604-1mg |
|
872313-42-3 |
Compound 2
|
0 | C21H23ClO6 | |
GC31603-50mg |
|
119-13-1 |
Delta-Tocopherol
|
0 | C27H46O2 | |
GC31602-10mg |
|
28874-58-0 |
Adrenic Acid (cis-7,10,13,16-Docosatetraenoic acid)
|
0 | C22H36O2 | |
GC31599-25mg |
|
1241826-88-9 |
Soluble epoxide hydrolase inhibitor
|
0 | C18H12F5N5O3 | |
GC31599-10mg |
|
1241826-88-9 |
Soluble epoxide hydrolase inhibitor
|
0 | C18H12F5N5O3 | |
GC31599-5mg |
|
1241826-88-9 |
Soluble epoxide hydrolase inhibitor
|
0 | C18H12F5N5O3 | |
GC31598-20mg |
|
186390-35-2 |
CP-319340(free base)
|
0 | C27H23F3N4O | |
GC31598-10mg |
|
186390-35-2 |
CP-319340(free base)
|
0 | C27H23F3N4O | |
GC31598-5mg |
|
186390-35-2 |
CP-319340(free base)
|
0 | C27H23F3N4O | |
GC31598-1mg |
|
186390-35-2 |
CP-319340(free base)
|
0 | C27H23F3N4O | |
GC31597-100mg |
|
38363-41-6 |
(+)-Penbutolol ((R)-Penbutolol)
|
0 | C18H29NO2 | |
GC31597-50mg |
|
38363-41-6 |
(+)-Penbutolol ((R)-Penbutolol)
|
0 | C18H29NO2 | |
GC31597-10mg |
|
38363-41-6 |
(+)-Penbutolol ((R)-Penbutolol)
|
0 | C18H29NO2 | |
GC31597-5mg |
|
38363-41-6 |
(+)-Penbutolol ((R)-Penbutolol)
|
0 | C18H29NO2 | |
GC31597-10mM(1mLinDMSO) |
|
38363-41-6 |
(+)-Penbutolol ((R)-Penbutolol)
|
0 | C18H29NO2 | |
GC31596-5mg |
|
482-53-1 |
Osajin (CID 95168)
|
0 | C25H24O5 | |